Final Programme - iuphar

FC09 Inflammation and immunopharmacology:
New tools for old diseases
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),
Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands)
FC09.4 NSAIDs and COX-2 inhibitors. Current strategies and future directions
Chairs: Jane A Mitchell, (UK) & Per-Johan Jakobsson, (Sweden)
14:30 - 14:55 FC09.4.1 Pharmacology of COX-1 and COX-2: Is there still a place for COX-2 selective NSAIDs?
Jane A Mitchell, (UK)
14:55 - 15:20 FC09.4.2 Anti-inflammatory benefits and cardiovascular toxicity of NSAIDs and COX-2 inhibitors
Paola Patrignani, (Italy)
15:20 - 15:45 FC09.4.3 COX-2 and gastric carcinogenesis
Ari Ristimäki, (Finland)
15:45 - 16:15 COFFEE BREAK
16:15 - 16:40 FC09.4.4 Inhibitors of microsomal PGE synthase-1
Per-Johan Jakobsson, (Sweden)
16:40 - 17:05 FC09.4.5 Endocannabinoids and beyond. Paracetamol, NSAIDs and novel mechanisms to treat
inflammatory pain
Peter Zygmunt, (Sweden), E Högestätt
17:05 - 17:20 FC09.4.6 Free Communication Presentation:
The role of formyl peptide receptor 2 (Fpr2) in leukocytes trafficking
Vincenzo Brancaleone, (UK), N Dufton, J Dalli, RJ Flower, M Perretti
IUL IUPHAR Plenary Lecture
Chair: Sue P Duckles, (USA)
17:30 - 18:15 IUL The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old
Paul M Vanhoutte, (PR China)
IUPHAR general assembly in Auditorium 15
Tuesday 20 July 18:30
Supported by the ASPET Division for Drug Discovery, Drug Development, and Regulatory Affairs
Tuesday 20 July ■ 14:30 - 18:15 ■ Hall A2 89